BioNexus Gene Lab Corp

BGLC

Exchange: Nasdaq
Industry: Services-Medical Laboratories
SEC CIK: 0001737523

SEC filings (opens in a new tab)

No open-market purchases or sales by BioNexus Gene Lab Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $27.2K in total; no superinvestor holds it.

Superinvestors holding BGLC, Q2 2026

See all superinvestors

No superinvestor reported holding BGLC in Q2 2026.